第一作者机构:[1]Acad Mil Med Sci 307th Hosp Chinese Peoples Lib, Affiliated Hosp Canc Ctr, Dept Gastrointestinal Oncol, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
Xu J.,Li J.,Bai C. M.,et al.An Open-Label Phase Ib/II Study of Sulfatinib in Patients with Advanced Neuroendocrine Tumors (NCT02267967)[J].NEUROENDOCRINOLOGY.2017,105:228-228.
APA:
Xu, J.,Li, J.,Bai, C. M.,Xu, N.,Zhou, Z. W....&Su, W. G..(2017).An Open-Label Phase Ib/II Study of Sulfatinib in Patients with Advanced Neuroendocrine Tumors (NCT02267967).NEUROENDOCRINOLOGY,105,
MLA:
Xu, J.,et al."An Open-Label Phase Ib/II Study of Sulfatinib in Patients with Advanced Neuroendocrine Tumors (NCT02267967)".NEUROENDOCRINOLOGY 105.(2017):228-228